Baseline characteristics in 299 patients randomly assigned to LX4211 or placebo in this 12-week dose-ranging study were similar : mean age 55.9 years , A1C 8.1 % ( 65 mmol/mol ) , BMI 33.1 kg/m ( 2 ) , and BP 124/79 mmHg .